Introduction to New Approach Methodologies (NAMs)
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures…
New Approach Methodologies, or NAMs, are modern strategies used to study biological responses while reducing reliance on vertebrate animal models.
For instance, computational approaches are used to analyze the structure of a test compound, identify relevant target proteins, and evaluate compound–protein interactions to predict potential biological effects.
Also, non-animal methods, such as cell-based assays and organ-on-chip systems, are selected based on the research objective. For example, cells can be treated with a test compound to evaluate its cytotoxicity.
Further, different concentrations of a test compound can be evaluated in controlled in vitro environments to determine an effective concentration before progressing to animal models.
In some cases, alternative animal models, such as zebrafish embryos or Drosophila, are used to further refine compound selection. For example, the effects of a test compound on zebrafish embryo development can be evaluated to assess toxicity.
Together, these approaches reduce reliance on traditional vertebrate animal models.
View the full transcript and gain access to JoVE Science Education videos
Q1: What are New Approach Methodologies and why are they used in research?
New Approach Methodologies (NAMs) are modern scientific strategies that generate biological data while reducing reliance on traditional vertebrate animal models. NAMs include computational modeling, cell-based assays, organ-on-chip systems, and alternative animal models like zebrafish embryos. These approaches support the 3Rs principle—Replacement, Reduction, and Refinement—enabling researchers to conduct ethical, efficient studies with human-derived cells and tissues.
Q2: How do computational approaches contribute to New Approach Methodologies?
Computational methods analyze test compound structures, identify relevant target proteins, and evaluate compound-protein interactions to predict potential biological effects. These approaches help prioritize compounds for further testing before moving to laboratory studies. By identifying promising candidates early, computational modeling reduces the number of compounds requiring experimental evaluation and supports more efficient research planning.
Q3: What role do cell-based assays play in NAMs?
Cell-based assays are non-animal methods used to evaluate compound effects under controlled in vitro conditions. Cells can be treated with test compounds to assess cytotoxicity, and different concentrations can be tested to determine effective doses before progressing to animal models. These assays provide mechanistic and toxicity-related information while reducing the need for vertebrate animal studies.
Q4: How are alternative animal models used within NAMs?
Alternative animal models such as zebrafish embryos and Drosophila (fruit flies) are used to refine compound selection and evaluate toxicity effects. For example, zebrafish embryo development can be assessed to determine compound safety before testing in traditional vertebrate models. These alternatives provide valuable biological data while supporting the principles of Replacement and Reduction in research.
Q5: What are organ-on-chip systems and how do they support NAMs?
Organ-on-chip systems are advanced in vitro technologies that mimic organ function in controlled laboratory environments. These systems allow researchers to study biological processes and evaluate compound effects with greater physiological relevance than traditional cell cultures. By providing realistic tissue responses, organ-on-chip systems reduce the need for animal testing while generating high-quality biological data.
Q6: How does integrating multiple NAM approaches improve research outcomes?
Integrating data from computational methods, cell-based assays, organ-on-chip systems, and alternative animal models creates a comprehensive evaluation strategy. Computational methods prioritize compounds, in vitro systems provide mechanistic data, and alternative models offer additional safety assessment. This integrated approach identifies promising compounds and potential hazards early, improving study design, reducing animal use, and supporting more efficient research.
Q7: What ethical principles guide the use of NAMs in research?
NAMs are designed to support the 3Rs principle: Replacement (using non-animal methods), Reduction (minimizing animal numbers), and Refinement (improving animal welfare). All animal procedures must comply with institutional ethics guidelines and IACUC approval. By using human-derived cells and tissues and identifying safety concerns early, NAMs help researchers conduct ethical studies that reduce vertebrate animal reliance while maintaining scientific rigor.